Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Methamphetamine
100%
HIV Neuropathogenesis
100%
Chemokine Ligand 12 (CXCL12)
100%
CXCR7
75%
CD16+ Monocytes
75%
Blood-brain Barrier
75%
People Living with HIV (PLHIV)
62%
C-X-C Chemokine Receptor Type 4 (CXCR4)
62%
Transmigration
62%
HIV-NCI
50%
Methamphetamine Use Disorder
37%
HIV+
25%
Monocyte Transmigration
25%
CD14+CD16+
25%
HIV-associated Neurocognitive Disorders
25%
HIV-infected Patients
25%
Interventional Strategies
12%
CXCR4 Expression
12%
Stromal Cell-derived factor-1 (SDF-1)
12%
Mediating Effect
12%
Chemotaxis
12%
In Vivo Effects
12%
Blood-brain Barrier Model
12%
Virus
12%
Monocytes
12%
Therapeutic Target
12%
Adhesion
12%
Replenishment
12%
Infected Macrophages
12%
Neuroinflammation
12%
Chemokine CXCL12
12%
Atypical Chemokine Receptor
12%
Chemokines
12%
Quality of Life
12%
Initial Infection
12%
Viral Reservoir
12%
Antiretroviral Therapy
12%
CNS Tissue
12%
Macrophage Accumulation
12%
Macaque
12%
Neurocognitive Impairment
12%
Monocytes/macrophages
12%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Monocyte
55%
CD14
44%
CD16
44%
Blood Brain Barrier
33%
CXCR7
33%
CXCR4
33%
Macrophage
11%
Stromal Cell-Derived Factor 1
11%
Chemokine Receptor
5%
Chemotaxis
5%
Simian Immunodeficiency Virus
5%
Tissue Section
5%
Prevalence
5%
Macaca
5%
Chemokine
5%
Virus
5%
Viral Reservoir
5%
Infection
5%
In Vitro
5%
Nervous System Inflammation
5%
Neuroinflammation
5%
Infectious Disease
5%
Therapeutic Target
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Blood-Brain Barrier
35%
Diseases
23%
Stromal Cell Derived Factor 1
11%
Infection
5%
Virus
5%
HIV Associated Dementia
5%
Chemokine Receptor
5%
Chemokine
5%
Macaca
5%
Simian Immunodeficiency Virus
5%
Nervous System Inflammation
5%
Prevalence
5%